November 4, 2025 — Maze Therapeutics, Inc. (Nasdaq: MAZE) will participate in four upcoming investor conferences.
The schedule includes a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11, 2025, at 9:30 a.m. ET. Another fireside chat will occur at the TD Cowen Immunology & Inflammation Summit on Thursday, November 13, 2025, at 2:00 p.m. ET. Additionally, the company will present at the Jefferies Global Healthcare Conference in London on Thursday, November 20, 2025, at 12:00 p.m. GMT / 7:00 a.m. ET and at the 8th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025, at 10:25 a.m. ET.
Live webcasts will be available in the Investors section of the Maze Therapeutics website and archived for 60 days.
Maze Therapeutics is a clinical-stage biopharmaceutical company developing small molecule precision medicines for kidney and metabolic diseases.
IR/Corporate Contact: Amy Bachrodt, Maze Therapeutics, abachrodt@mazetx.com; Media Contact: Amanda Lazaro, 1AB Media, Amanda@1ABMedia.com
Source: Maze Therapeutics, Inc.
